ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2014

Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet.

Steven P Vickers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.